A pilot comparative study of quantitative ultrasound, conventional ultrasound, and MRI for predicting histology-determined steatosis grade in adult nonalcoholic fatty liver disease

American Journal of Roentgenology

Volumn 208, Issue 5, 2017, Pages W168-W177

  Paige, Jeremy S ^a   Bernstein, Gregory S ^a   Heba, Elhamy ^a   Costa, Eduardo A C ^a   Fereirra, Marilia ^a   Wolfson, Tanya ^a,b   Gamst, Anthony C ^a,b   Valasek, Mark A ^c   Lin, Grace Y ^c   Han, Aiguo ^d   Erdman, John W ^e   O'Brien, William D ^d   Andre, Michael P ^a,f   Loomba, Rohit ^b   Sirlin, Claude B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d University of Illinois at Urbana Champaign   (United States)

^e UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^f VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Attenuation; Backscatter; Grading accuracy; Interobserver agreement; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Proton density fat fraction; Quantitative imaging biomarkers; Quantitative ultrasound

Indexed keywords

ADULT; AGED; ARTICLE; ATTENUATION COEFFICIENT; B SCAN; BACK SCATTER COEFFICIENT; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; ECHOGRAPHY; FEMALE; FIBROSIS; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVER BIOPSY; LIVER CELL DAMAGE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PHYSICAL PARAMETERS; PILOT STUDY; PRIORITY JOURNAL; RADIOGRAPHY DEVICE; RADIOLOGY PHANTOM; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STEATOSIS; VALIDATION PROCESS; BIOPSY; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC IMAGING; IMAGING PHANTOM; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROSPECTIVE STUDY;

ADULT; AGED; BIOPSY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PHANTOMS, IMAGING; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ULTRASONOGRAPHY;

EID: 85018325757     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.16.16726     Document Type: Article

References (26)

1. Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 2013; 10:686-690
2. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD; American Association for the Study of Liver Diseases. Liver biopsy. Hepatology 2009; 49:1017-1044
3. Tang A, Desai A, Hamilton G, et al. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 2015; 274:416-425
4. Shah PK, Mudaliar S, Chang AR, et al. Effects of intensive insulin therapy alone and in combination with pioglitazone on body weight, composition, distribution and liver fat content in patients with type 2 diabetes. Diabetes Obes Metab 2011; 13:505-510
5. Khov N, Sharma A, Riley TR. Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20:6821-6825
6. Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010; 53:372-384
7. Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123:745-750
8. Bohte AE, van Werven JR, Bipat S, Stoker J. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: A meta-analysis. Eur Radiol 2011; 21:87-97
9. Dasarathy S, Dasarathy J, Khiyami A, Joseph R, Lopez R, McCullough AJ. Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study. J Hepatol 2009; 51:1061-1067
10. Kim SH, Lee JM, Kim JH, et al. Appropriateness of a donor liver with respect to macrosteatosis: application of artificial neural networks to US images-initial experience. Radiology 2005; 234:793-803
11. Strauss S, Gavish E, Gottlieb P, Katsnelson L. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR 2007; 189:[web]W320-W323
12. Williamson RM, Perry E, Glancy S, et al. The use of ultrasound to diagnose hepatic steatosis in type 2 diabetes: intra-and interobserver variability and comparison with magnetic resonance spectroscopy. Clin Radiol 2011; 66:434-439
13. Lin SC, Heba E, Wolfson T, et al. Noninvasive diagnosis of nonalcoholic fatty liver disease and quantification of liver fat using a new quantitative ultrasound technique. Clin Gastroenterol Hepatol 2015; 13:1337-1345
14. Yao LX, Zagzebski JA, Madsen EL. Backscatter coefficient measurements using a reference phantom to extract depth-dependent instrumentation factors. Ultrason Imaging 1990; 12:58-70
15. Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: A population-based cohort study. Gastroenterology 2005; 129:113-121
16. Tang A, Tan J, Sun M, et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 2013; 267:422-431
17. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41:1313-1321
18. Brunke SS, Insana MF, Dahl JJ, Hansen C, Ashfaq M, Ermert H. An ultrasound research interface for a clinical system. IEEE Trans Ultrason Ferroelectr Freq Control 2007; 54:198-210
19. Ballestri S, Lonardo A, Romagnoli D, et al. Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. Liver Int 2012; 32:1242-1252
20. Yokoo T, Shiehmorteza M, Hamilton G, et al. Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 2011; 258:749-759
21. Hamilton G, Yokoo T, Bydder M, et al. In vivo characterization of the liver fat 1H MR spectrum. NMR Biomed 2011; 24:784-790
22. Ricci C, Longo R, Gioulis E, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol 1997; 27:108-113
23. Chan WK, Nik Mustapha NR, Mahadeva S. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease. J Gastroenterol Hepatol 2014; 29:1470-1476
24. Chon YE, Jung KS, Kim SU, et al. Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: A prospective study of a native Korean population. Liver Int 2014; 34:102-109
25. Kumar M, Rastogi A, Singh T, et al. Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance? J Gastroenterol Hepatol 2013; 28:1194-1201
26. Shen F, Zheng RD, Shi JP, et al. Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease. Liver Int 2015; 35:2392-2400